Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001827506-24-000072
Filing Date
2024-08-08
Accepted
2024-08-08 08:46:46
Documents
65
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q trml-20240630.htm   iXBRL 10-Q 1276308
2 EX-10.1 a06302024exhibit101.htm EX-10.1 33389
3 EX-31.1 a06302024exhibit311.htm EX-31.1 9499
4 EX-31.2 a06302024exhibit312.htm EX-31.2 9798
5 EX-32.1 a06302024exhibit321.htm EX-32.1 7650
  Complete submission text file 0001827506-24-000072.txt   5628854

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trml-20240630.xsd EX-101.SCH 37762
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT trml-20240630_cal.xml EX-101.CAL 48959
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT trml-20240630_def.xml EX-101.DEF 189555
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trml-20240630_lab.xml EX-101.LAB 447824
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trml-20240630_pre.xml EX-101.PRE 329472
68 EXTRACTED XBRL INSTANCE DOCUMENT trml-20240630_htm.xml XML 622374
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40384 | Film No.: 241186267
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)